Следене
Nilay D. Shah
Nilay D. Shah
Потвърден имейл адрес: mayo.edu
Заглавие
Позовавания
Позовавания
Година
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
164212014
Exposure to low-dose ionizing radiation from medical imaging procedures
R Fazel, HM Krumholz, Y Wang, JS Ross, J Chen, HH Ting, ND Shah, ...
New England Journal of Medicine 361 (9), 849-857, 2009
16192009
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ...
Circulation 147 (8), e93-e621, 2023
11622023
Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices
MD Abràmoff, PT Lavin, M Birch, N Shah, JC Folk
NPJ digital medicine 1 (1), 39, 2018
10022018
Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice
ND Shippee, ND Shah, CR May, FS Mair, VM Montori
Journal of clinical epidemiology 65 (10), 1041-1051, 2012
6792012
Increased mortality of patients with diabetes reporting severe hypoglycemia
RG McCoy, HK Van Houten, JY Ziegenfuss, ND Shah, RA Wermers, ...
Diabetes care 35 (9), 1897-1901, 2012
6062012
Hospitalizations after heart failure diagnosis: a community perspective
SM Dunlay, MM Redfield, SA Weston, TM Therneau, K Hall Long, ...
Journal of the American College of Cardiology 54 (18), 1695-1702, 2009
6052009
Non–vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction
X Yao, ND Shah, LR Sangaralingham, BJ Gersh, PA Noseworthy
Journal of the American College of Cardiology 69 (23), 2779-2790, 2017
5132017
Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States
KC Siontis, X Zhang, A Eckard, N Bhave, DE Schaubel, K He, A Tilea, ...
Circulation 138 (15), 1519-1529, 2018
4692018
Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation
X Yao, NS Abraham, LR Sangaralingham, MF Bellolio, RD McBane, ...
Journal of the American Heart Association 5 (6), e003725, 2016
4682016
Randomized trial of rapid multiplex polymerase chain reaction–based blood culture identification and susceptibility testing
R Banerjee, CB Teng, SA Cunningham, SM Ihde, JM Steckelberg, ...
Clinical Infectious Diseases 61 (7), 1071-1080, 2015
4572015
Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation
X Yao, NS Abraham, GC Alexander, W Crown, VM Montori, ...
Journal of the American Heart Association 5 (2), e003074, 2016
4542016
Potential overtreatment of diabetes mellitus in older adults with tight glycemic control
KJ Lipska, JS Ross, Y Miao, ND Shah, SJ Lee, MA Steinman
JAMA internal medicine 175 (3), 356-362, 2015
4382015
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
NS Abraham, S Singh, GC Alexander, H Heien, LR Haas, W Crown, ...
bmj 350, 2015
4302015
Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012
NS Downing, JA Aminawung, ND Shah, HM Krumholz, JS Ross
Jama 311 (4), 368-377, 2014
4292014
Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000–2010
M Daubresse, HY Chang, Y Yu, S Viswanathan, ND Shah, RS Stafford, ...
Medical care 51 (10), 870-878, 2013
4272013
Optum Labs: building a novel node in the learning health care system
PJ Wallace, ND Shah, T Dennen, PA Bleicher, WH Crown
Health affairs 33 (7), 1187-1194, 2014
3822014
NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
WA He, E Berardi, VM Cardillo, S Acharyya, P Aulino, J Thomas-Ahner, ...
The Journal of clinical investigation 123 (11), 4821-4835, 2013
3742013
Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers
J Deiuliis, Z Shah, N Shah, B Needleman, D Mikami, V Narula, K Perry, ...
PloS one 6 (1), e16376, 2011
3552011
Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013
KJ Lipska, X Yao, J Herrin, RG McCoy, JS Ross, MA Steinman, ...
Diabetes care 40 (4), 468-475, 2017
3362017
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20